Equashield a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced that its Singapore distributor, Transmedic Pte Ltd., will begin distribution of Equashield's specialized Closed System Transfer Devices (CSTDs) in Hong Kong. 

"Our facilities in Singapore were very satisfied with Equashield's high level of safety and quality compared with competing CSTDs," said Helen Au, Regional Senior Product Manager for Transmedic Pte Ltd. "We are pleased to introduce Equashield's leading solution to our Hong Kong healthcare facilities and are confident that as market education and awareness of the dangers of hazardous drug exposure increases, our customers will value the quality and safety inherent in Equashield's CSTD." 

Hong Kong is a developing market in its approach to safe handling practices and continues to be influenced by the regulatory landscape in the United States. Despite the mainstream acceptance of CSTDs as a standard of care in the United States, most major Hong Kong hospitals and chemotherapy centers opt to use drug ventilators and isolators instead of CSTDs for their hazardous drug compounding needs. 

"Hospitals and healthcare facilities not using closed systems put their professional staff at risk of dangerous hazardous drug exposure," said Adi Shor, VP Sales ROW for Equashield. "Our current goal with our partners in Hong Kong revolves around market education. There is ample evidence demonstrating the dangers of hazardous drug exposure to healthcare professionals, and even more evidence asserting that implementing a truly closed system drastically reduces environmental contamination and exposure to hazardous drugs. Our hope is that with increased awareness, health care facilities will choose to implement Equashield's truly closed system."